Milestone Capital Revenue and Competitors
Employee Data
- Milestone Capital has 31 Employees.
- Milestone Capital grew their employee count by 7% last year.
Milestone Capital's People
Name | Title | Email/Phone |
---|
Milestone Capital Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 31 | 7% | N/A | N/A |
What Is Milestone Capital?
Milestone Capital manages three U.S. dollar private equity funds which invest primarily in established high-growth companies seeking expansion or acquisition capital in China. The Funds seek to maximize medium to long term capital appreciation by making direct investments to acquire minority or majority equity stakes in those companies identified by Milestone’s investment team. Milestone Capital has a strong track record in helping portfolio companies list on either domestic or foreign stock exchanges. We leverage our extensive network of advisors, industry executives, portfolio companies as well as business relationships to bring superior value-added support to our portfolio companies from both financial and strategic angles. To date, ten of our portfolio companies have listed on major overseas stock exchanges. In July 2005, Focus Media Holdings Limited ( Ticker: FMCN), listed on the NASDAQ; in December 2006, Trina Solar Limited (Ticker: TSL) listed on the New York Stock Exchange; in December 2007, VisionChina Media Inc. (Ticker: VISN) listed on the NASDAQ, in July 2009, GCL Silicon Technology Holdings Inc. (“GCL Siliconâ€) was acquired by a listed company GCL-Poly Energy Holdings Limited (Ticker: 3800.HK), in April 2010, Dehaier Medical Systems Limited (“Dehaierâ€) successfully listed on the NASDAQ (Ticker: DHRM), in July 2012, Xiao Nan Guo Restaurants Holdings Limited (Ticker: 3666.HK) listed on the Hong Kong Stock Exchange (“HKSEâ€); in September 2013, Tenwow International Holding Limited (Ticker: 1219.HK) listed on the HKSE; in October 2013, Cabbeen Fashion Limited (Ticker: 2030.HK) listed on the HKSE; in September 2015, JHL Biotech (Ticker: 6540.TW) listed on the Emerging Stock Board of Taipei Exchange. In June 2017, Aslan Pharmaceutical (Ticker: 6497) listed on the Main Board of Taipai Exchange.
keywords:N/AN/A
Total Funding
31
Number of Employees
N/A
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 31 | 11% | N/A |
#2 | $8.2M | 31 | -11% | N/A |
#3 | $3M | 37 | -3% | N/A |
#4 | $6.5M | 37 | -29% | N/A |
#5 | $8.4M | 38 | 23% | N/A |